Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan - FDA Press Releases

FDA releases Biosimilars Action Plan to address competition and affordability for biologics and biosimilar products.

from Food and Drug Administration--Press Releases https://ift.tt/2L73qBx
via IFTTT